Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

59 clinical studies listed.

Filters:

Headache

Tundra lists 59 Headache clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT07950033

A Study to Evaluate the Effects of the EMF Harmony Products on Health Parameters Associated With EMF Radiation Exposure

This is a randomized, double-blind, placebo-controlled, fully decentralized (virtual) clinical trial evaluating the effects of the EMF Harmony products (Pure Light Cuff and Smartwatch Chip) on health parameters associated with EMF radiation exposure. Sixty adult participants aged 18-65 will be randomized 1:1 to either the active treatment or an identical placebo for 6 weeks of continuous daily wear. Participants will complete validated questionnaires at Baseline, Week 2, Week 4, and Week 6, and will wear a Fitbit Tracker throughout the study to collect objective data on sleep metrics, heart rate variability (HRV), and resting heart rate. The primary objective is to evaluate whether daily use of the EMF Harmony products produces measurable improvements in composite health parameters compared to placebo over 6 weeks.

Gender: All

Ages: 16 Years - 65 Years

Updated: 2026-11-20

1 state

Electromagnetic Hypersensitivity
Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields
Sleep Disturbance
+4
RECRUITING

NCT06112093

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.

Gender: All

Ages: 18 Years - 55 Years

Updated: 2026-11-19

1 state

Brain Concussion
Mild Traumatic Brain Injury
Headache
+1
COMPLETED

NCT07948460

Headache and Nasal Dysfunction in Children

Headaches in pediatric patients can be related to primary (essential) and secondary (symptomatic) causes. This study investigates the correlation between nasal dysfunction, specifically mucociliary clearance impairment and structural anomalies, and cephalalgia in children, with a focus on allergic rhinitis and rhinopathy. A total of 2,262 children aged 5 to 10 years were screened. Clinical evaluation included evaluation of headache history, nasal patency, mucociliary clearance function, and the presence of structural anomalies such as septal deviation or adenoidal hypertrophy. A significant association was found between nasal dysfunction and headache. Children with impaired mucociliary clearance, nasal obstruction, or structural abnormalities demonstrated a higher prevalence of cephalalgia compared to those with normal nasal function. Allergic rhinitis was frequently observed among patients who reported recurrent headaches. Altered nasal dysfunction appears to be an important and potentially underrecognized contributor to pediatric headache. These findings highlight the need for comprehensive Ear Nose Throat evaluation in children with recurrent and unexplained cephalalgia.

Gender: All

Ages: 5 Years - 10 Years

Updated: 2026-11-19

1 state

Headache
Nasal Airway
RECRUITING

NCT07661758

Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section

This prospective randomized controlled multicenter study will be conducted to evaluate the effects of pre-emptive IV lidocaine dose on the incidence and severity of intraoperative headache that may occur after the extra-abdominal manual uterine fundal pressure in patients undergoing cesarean section under spinal anesthesia.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-11-16

1 state

Intravenous Lidocaine
Fundal Pressure
Headache
NOT YET RECRUITING

NCT07764783

Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine

The goal of this double-blinded, randomized placebo controlled clinical trial is to to see if using a numbing medicine (lidocaine) on certain areas inside the nose can help with headaches, neck pain, facial pain and pressure, and other symptoms. It also aims to understand the pathophysiology that causes these symptoms. The main questions it aims to answer are: 1. Is applying numbing medication directly to the sphenopalatine ganglion (SPG) area, while watching through the scope to make sure it's in the right place, a workable and effective way to treat migraine headaches immediately and 24 hours? 2. Is applying numbing medication directly to the sphenopalatine ganglion (SPG) area, while watching through the scope to make sure it's in the right place, a workable and effective way to improve patient-reported outcomes? 3. Does daily lidocaine nasal spray improve patient-reported outcomes? The 3-month study requires: * One virtual visit (on the computer) * One visit to the office for placement of the numbing medicine under direct vision * One week of daily nasal spray treatment * Daily headache diary entries that take less than two minutes to complete

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-09

1 state

Migraine
Facial Pain or Pressure
Headache
ENROLLING BY INVITATION

NCT07297901

App-based Breathing Program for Migraine Relief

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-05

1 state

Migraine
Heart Rate Variability (HRV)
Autonomic Nervous System
+5
RECRUITING

NCT07294118

Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage

The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.

Gender: All

Ages: 18 Years - 100 Years

Updated: 2026-11-03

1 state

Subarachnoid Hemorrhage, Aneurysmal
Headache
Opiate Dependence
+1
COMPLETED

NCT07898722

Impact of Optimized White Light on Visual Discomfort, Headache Intensity, and Cognitive Performance Among Those With Migraine

The goal of this research is to study how effective an optimized white light is for improving visual comfort and reducing migraine symptoms. To do so, we will compare the effects of an optimized white light with those of a standard, commercially available white light. The main study objectives are to: 1. Compare the effects of an optimized white light spectrum vs. a conventional white light on visual discomfort levels in people with and without migraine. 2. Evaluate the effects of each lighting condition on headache intensity, cognitive performance, and pupil size. This study will inform the design of more comfortable lighting environments for individuals with migraine. The implementation of optimized white light in healthcare settings, offices, schools, and homes may serve as a practical strategy to improve comfort and reduce symptoms for those with migraine.

Gender: All

Ages: 18 Years - 45 Years

Updated: 2026-10-27

1 state

Migraine
Photophobia
Cognitive Function Assessment
+3
RECRUITING

NCT07361549

Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment

The goal of this clinical trial is to test whether injecting lidocaine into two blood vessels of the brain can help treat chronic headaches (migraines)

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-01

1 state

Refractory Migraine
Headache
COMPLETED

NCT07699549

Long-term Atogepant in Real-world Practice

This prospective multicentre observational study aims to evaluate the long-term effectiveness, safety, tolerability, and treatment persistence of atogepant for migraine prevention in routine clinical practice. Adult patients with migraine initiating atogepant across 15 tertiary Headache Units in Spain are followed for 12 months. Clinical outcomes, including monthly headache days, monthly migraine days, medication overuse, adverse events, treatment discontinuation, and patient-reported outcomes in a subset of participants, are assessed at baseline and after 3, 6, and 12 months. The study also characterizes different response trajectories, including sustained, delayed, and transient responses, in a real-world population with high disease burden and multiple prior preventive treatment failures.

Gender: All

Ages: 18 Years - Any

Updated: 2026-09-23

1 state

Migraine
Headache
Headache (Migraine)
+4
ACTIVE NOT RECRUITING

NCT04715685

Mind Body Balance for Pediatric Migraine

This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized treatment for headache day reduction.

Gender: All

Ages: 10 Years - 17 Years

Updated: 2026-09-22

2 states

Headache
Headache Disorders
Headache, Migraine
+5
RECRUITING

NCT06670053

Puberty, Testosterone, and Brain Development

Transmasculine youth (female sex assigned at birth, male gender identity) who begin clinical gender affirming hormone therapy (GAHT) with testosterone (T) may experience changes in headache. Researchers think this because studies published on effects of giving testosterone to cisgender females (female sex, female gender identity) and transmasculine adults seem to show an effect on pain. This research will help us learn more about changes in headache and in brain structure and function in transmasculine youth during the first year of T. Youth who will be starting T within 6 months, either on puberty blocker or not, as part of their regular medical care can participate and will be asked to attend 3 visits: * before starting T * after 6 months on T * after 1 year on T At the visits, they will be asked to: * answer questions and surveys about their health * have a brain MRI done * give a small sample of blood and at their first visit, complete a physical exam. Some participants can also do a brief test of pain sensitivity. All participants will be asked to complete a headache diary for the first 6 months and for 1 month after the 1 year visit.

Gender: All

Ages: 12 Years - 20 Years

Updated: 2026-09-21

1 state

Gender Identity
Gender Dysphoria in Adolescents and Adults
Headache
+1
RECRUITING

NCT05889624

Responding With Evidence and Access for Childhood Headaches

This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it. CBT via telehealth while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) will be compared to CBT via telehealth alone.

Gender: All

Ages: 10 Years - 17 Years

Updated: 2026-09-21

14 states

Headache
Headache Disorders
Headache, Migraine
+5
ACTIVE NOT RECRUITING

NCT05607303

Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty

With a rising population of transgender adults and youth, there is a need for more research to meet the needs of this community. Transfemale (MTF) youth (male sex, female gender identity) who begin clinical Gender Affirming Hormone Therapy (GAHT) with estrogen may be at a higher risk for headache since estrogen has been linked to headache in cisgender females (female sex, female gender identity). This research hopes to learn more about headache in MTF youth.

Gender: All

Ages: 9 Years - 20 Years

Updated: 2026-09-16

1 state

Headache
Gender Identity
NOT YET RECRUITING

NCT07817446

Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study

The goal of this observational study is to learn how common headache and migraine are and to describe headache patterns among transgender adults in Thailand. The main questions it aims to answer are: * How common are headache and migraine among transgender adults in Thailand? * What headache patterns and levels of headache-related disability do participants report? * Are gender-affirming hormone therapy, gender-affirming surgery, or HIV pre-exposure prophylaxis (PrEP) use related to headache or migraine? About 500 transgender adults aged 18 years or older who currently attend or previously attended the Tangerine Clinic in Bangkok, Thailand, will take part. Participants will: * Provide consent online * Complete an online questionnaire about their general health and headache symptoms * Answer questions about gender-affirming hormone therapy, gender-affirming surgery, and PrEP use * Complete questionnaires that screen for migraine and measure how headaches affect daily activities This study will not assign any treatment or change the participants' usual medical care.

Gender: All

Ages: 18 Years - Any

Updated: 2026-09-14

Headache
Migraine
COMPLETED

NCT06471426

The Effect of Osteopathic Treatment on Craniocervico-Mandibular Dysfunction

The goal of this clinical trial is to measure the effects of osteopathic manipulative treatment (OMT) on tissues of the craniocervico-mandibular unit (CCMU) in individuals with neck pain and headaches. The main questions to answer are: 1. How does OMT affect CCMU muscle stiffness 2. How does OMT affect jaw motion 3. How does OMT affect autonomic function 4. Is pain pressure threshold affected by OMT of the CCMU Participants will undergo the following interventions: 1. Photos taken to measure head and neck angles 2. Ultrasound 3. Smooth Pursuit Neck Torsion Test 4. Motion Capture 5. Autonomic Protocol 6. Algometry 7. Surveys

Gender: All

Ages: 19 Years - 65 Years

Updated: 2026-09-11

1 state

Headache
Neck Pain
COMPLETED

NCT05445427

Vagal Nerve Stimulation for Post COVID Fatigue

The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.

Gender: All

Ages: 18 Years - Any

Updated: 2026-09-09

1 state

Post COVID Syndrome
Fatigue
Headache
COMPLETED

NCT07487649

Treatment Response in Patients With Medication-Overuse Headache

The aim of this study to evaluate pre-injection patient-related factors that may influence treatment response in patients with medication-overuse headache who underwent ultrasound-guided greater occipital nerve block.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-09-09

Medication-overuse Headache
Treatment
Headache
+1
RECRUITING

NCT07725198

Immediate Neuromuscular Responses of the Obliquus Capitis Inferior Following Upper Cervical Manual Therapy

This study used a prospective, randomized, repeated-measures experimental design to investigate the immediate effects of two upper cervical manual therapy interventions on craniovertebral angle (CVA), clinician-perceived atlas position, and musculoskeletal ultrasound-derived obliquus capitis inferior (OCI) muscle morphology

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-08-28

1 state

Head and Neck
Headache
RECRUITING

NCT04685772

Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches

This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.

Gender: All

Ages: 18 Years - Any

Updated: 2026-08-26

1 state

Post-Concussion Syndrome
Headache
RECRUITING

NCT06621329

Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.

Gender: All

Ages: 18 Years - 100 Years

Updated: 2026-08-18

1 state

SAH (Subarachnoid Hemorrhage)
Headache
RECRUITING

NCT07754266

Headache Ear Auditory Dizziness Sinus (HEADS) Registry

The Headache, Ear, Auditory, Dizziness, Sinus (HEADS) Registry is a study over time of individuals living in the United States who experience sinus, vestibular, auditory, and headache symptoms. Through an online portal, participants are asked questions about their symptoms, how they have affected their lives, and how effectively they have managed them. This information is then used to better understand these symptoms and to improve patient diagnosis and treatment. Some potential research benefits of the HEADS Registry include: * Improving healthcare professionals' understanding of the causes of specific head and neck symptoms. * Reducing delays in diagnosis and the use of inappropriate tests, medications, and surgeries. * Finding the most effective treatments for sinus, vestibular, and auditory disorders. * Providing participants the opportunity to be contacted for additional important research related to sinus, vestibular, and auditory disorders. All U.S. residents over the age of majority who experience sinus, vestibular, and auditory symptoms, with or without migraine, are eligible to participate. Enrollment is voluntary, confidential, and free of charge.

Gender: All

Ages: 18 Years - Any

Updated: 2026-08-10

1 state

Headache Disorders
Dizziness
Vestibular Diseases
+6
RECRUITING

NCT06582810

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significant reduction in pain scores in patients with moderate/severe headache pain following non-traumatic subarachnoid hemorrhage; 2. show that intravenous lidocaine infusion is safe in treating headache following non-traumatic subarachnoid hemorrhage; 3. and report vasospasm prevalence in the cohort. Participants will receive lidocaine infusion as treatment for non-traumatic subarachnoid hemorrhage headache and provide pain scores (on a numeric pain scale) every two hours the patients are awake for a maximum of seven days. Monitoring for vasospasm will occur as part of the patients regular medical care.

Gender: All

Ages: 18 Years - Any

Updated: 2026-07-10

1 state

Subarachnoid; Hemorrhage, Nontraumatic
Headache
RECRUITING

NCT06008795

BLOCK-SAH - PPF-Block for Post-SAH Headache

BLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of bilateral pterygopalatine fossa (PPF) injections with 20mg ropivacaine + 4mg dexamethasone (active, PPF-block) compared to saline (placebo) for headache in survivors of aneurysmal subarachnoid hemorrhage (SAH), while monitoring intracranial arterial mean flow velocities with transcranial Doppler (TCD) peri-intervention (intervention = PPF-injections: active or placebo)

Gender: All

Ages: 18 Years - 85 Years

Updated: 2026-07-06

11 states

Subarachnoid Hemorrhage, Aneurysmal
Headache